JPT Peptide Technologies is the acknowledged supplier of innovative peptide based products and services for vaccine development, immuno monitoring and peptide biomarker discovery worldwide.

JPT's core technologies Spot™, PepStar™ and PepMix™ for peptide arrays and peptide pools as well as it's premium synthesis unit for custom peptides contribute to all essential development phases of novel vaccines.

Employing these proprietary technologies in state-of-the-art facilities, it is our ambition to enable:

• High-throughput T-cell epitope discovery
  (SPOT™ micro-scale peptide sets for all T-cell assay systems such as ELISPOT, ICS and others)
• Proteome wide antibody signature profiling and B-cell epitope discovery (PepStar™ peptide microarrays)
• Antibody epitope mapping (PepSpot™ peptide membranes)
• In vitro profiling of anti-antibody / neutralizing antibody action (RepliTope™ peptide microarrays)
• Vaccine efficacy testing, immuno monitoring and adoptive immunotherapy research
  (PepMix™ - antigen spanning and mixed epitope peptide pools)
• Development of peptide based vaccines and synthesis of peptide standards for validation of T-cell assays
  (state of the art custom peptide synthesis)

JPT helps to accelerate vaccine development in an unparalleled way. Quality, turn-around time and price of our innovative products and services combined with the expertise and experience, and the responsiveness of our service make us a unique partner.